The usefulness of the QualityMetric Health Outcomes™ Scoring Software 5.0 for predicting the risk of depression in male partners of cancer patients

Marcin J. Jabłoński, Francisco Garcia-Torres, Paulina Zielińska, Alicja Bułat, Piotr Brandys, Marzena Samardakiewicz

Vol 18, No 4 (2022)

Review paper

Home-based treatment with subcutaneous trastuzumab: safe and acceptable not only during a pandemic — final analysis of the RWD project ‘FlexCare’

Barbara Radecka, Joanna Hudała-Klecha, Dariusz Sawka, Jolanta Sarga, Bożena Noworolska, Grażyna Susczyk, Jolanta Sawicka, Elżbieta Duda, Natalia Obruśnik, Patryk Zając

Vol 20, No 2 (2024)

Research paper

On the completion of the year 2022 for Oncology in Clinical Practice

Maciej Krzakowski, Łukasz Stolarczyk

Vol 18, No 6 (2022)

Editorial

Factors affecting change in renal function after contrast-enhanced computed tomography in cancer patients

Aleksandra Semeniuk-Wojtaś, Arkadiusz Lubas, Aneta Gawin, Maciej Małyszko, Maksymilian Baryła, Rafał Stec, Jolanta Małyszko

Vol 19, No 1 (2023)

Research paper

Expression of immune checkpoints on peripheral blood cells in patients with prostate cancer

Gabriel Surdacki, Bożena Sokołowska, Aneta Gorący, Katarzyna Chyl-Surdacka, Marek Hus

Vol 18, No 4 (2022)

Research paper

Response assessment in cancer immunotherapy. Cooperation between the oncologist and the radiologist

Jakub Pałucki, Jakub Kucharz

Vol 18, No 2 (2022)

Review paper

Survival outcomes of patients diagnosed with muscle-invasive bladder cancer who showed a response after neoadjuvant chemotherapy and refused radical cystectomy, and patients who had radical cystectomy or received chemoradiotherapy

Sezai Tunç, Zuhat Urakçı, Senar Ebinç, Serdar İleri, Ziya Kalkan, Zeynep Oruç, Mehmet Küçüköner, Muhammet Ali Kaplan, Abdurrahman Işıkdoğan

Vol 19, No 5 (2023)

Research paper

IgG4-related disease presenting with cholangitis mimicking cholangiocarcinoma: a case report with a literature review

Mohsenreza Mansoorian, Seyyed Amir Yasin Ahmadi, Shahriar Sabouri

Vol 18, No 5 (2022)

Case report

Recommendations for prevention of SARS-CoV-2 infection in immunocompromised patients

Krzysztof Tomasiewicz, Alicja Dębska-Ślizień, Magdalena Durlik, Krzysztof Giannopoulos, Iwona Hus, Piotr Rutkowski

Vol 19, No 2 (2023)

Guidelines / Expert consensus

Common statement of experts of the Polish Oncological Society, Polish Lung Cancer Group, Polish Society of Lung Diseases, Polish Society of Gastroenterology, Polish Society of Endocrinology, and the Polish Society of Cardiology for minimal requirements in diagnosis and monitoring of selected adverse events of immunotherapy in oncological patients

Bożena Cybulska-Stopa, Adam Antczak, Dariusz M. Kowalski, Beata Kos-Kudła, Tomasz Kubiatowski, Przemysław Leszek, Adam Maciejczyk, Jarosław Reguła, Paweł Wiechno, Piotr Rutkowski

Vol 19, No 2 (2023)

Guidelines / Expert consensus

Expert opinion on adjuvant treatment with osimertinib in patients with non-small cell lung carcinoma after radical tumor resection

Renata Langfort, Maciej Krzakowski, Dariusz M. Kowalski, Rafał Krenke, Tadeusz Orłowski, Witold Rzyman, Bartosz Wasąg

Vol 19, No 4 (2023)

Guidelines / Expert consensus

Opinion of representatives of the psycho-oncology community on the lack of coherent systemic solutions on the legal regulation of their profession

Kamila Kocańda, Michał Chrobot, Marzena Samardakiewicz, Marcin J. Jabłoński

Vol 19, No 5 (2023)

Research paper

Bisphosphonate treatment as a safe choice for treating lung metastases of recurrent giant cell tumor of bone

Hans Kristian Nugraha, Putu Bihan Surya Kinanta, I Gede Eka Wiratnaya

Vol 19, No 3 (2023)

Case report

Patterns of multiple primaries in fortyfour cancer patients: a single-center clinical experience

Mehmet Esat Duymus, Tolga Koseci, Mehmet Serindere, Meral Ceylan, Abdullah Bulgurcu, Ozlem Ipci, Cemile Karadeniz, Yusuf Murat Bag, Dilsa Mizrak Kaya

Vol 19, No 1 (2023)

Research paper

Management of febrile neutropenia in a breast cancer patient with SARS-CoV-2 infection during dose-dense adjuvant chemotherapy

Joanna Terebińska, Robert Wojciechowski, Filip Zieliński, Anna Skrzypczyk-Ostaszewicz, Arkadiusz Zegadło, Emil Lisiak, Artur Maliborski, Renata Duchnowska

Vol 19, No 2 (2023)

Clinical vignette

A case of pathologic complete response after neoadjuvant triplet chemotherapy for locally advanced colon cancer with mismatch repair enzyme proficiency

Mehmet Zahid Kocak, Murat Cakir, Ulku Kerimoglu, Murat Araz, Melek Karakurt Eryilmaz, Perran Fulden Yumuk, Mehmet Artac

Vol 19, No 2 (2023)

Case report

Ripretinib in the treatment of patients with advanced gastrointestinal stromal tumors (GIST)

Emilia Babula, Aleksandra Sikora, Paweł Sobczuk, Piotr Rutkowski

Vol 20, No 1 (2024)

Review paper

Nivolumab in the treatment of thoracic cancer — new possibilities

Magdalena Knetki-Wróblewska, Kamila Wojas-Krawczyk

Vol 19, No 4 (2023)

Review paper

Implementation of the Polish version of the 11th revision of the International Statistical Classification of Diseases and Related Health Problems (ICD-11): importance for oncology

Magdalena Sakowicz, Beata Jagielska, Lubomir Bodnar, Janusz Jaroszyński, Maciej Krzakowski

Vol 19, No 5 (2023)

Review paper

Optimizing treatment strategies for a MET exon 14 skipping mutation in non-small-cell lung cancer: a case report of sequential immunotherapy and targeted therapy and literature review

Maria Grodkiewicz, Pawel Kozieł, Izabela Chmielewska, Anna Grenda, Paweł Krawczyk, Janusz Milanowski

Vol 19, No 6 (2023)

Case report

Low-grade serous ovarian cancer with BRAFV600E mutation treated with metronomic chemotherapy — a case report and literature review

Maria Rozpłoch-Sapa, Patrycja Mrowczyk, Łukasz Kwinta, Mateusz Łobacz, Paweł M. Potocki

Vol 20, No 1 (2024)

Case report

Recent advances in the treatment of triple-negative breast cancer

Katarzyna Pogoda, Agnieszka Jagiełło-Gruszfeld, Michał Kunkiel, Anna Niwińska, Zbigniew Nowecki

Vol 19, No 6 (2023)

Review paper

Fertility preservation during oncological treatment

Joanna Kufel-Grabowska, Krzysztof Łukaszuk, Magdalena Błażek, Agnieszka Jagiełło-Gruszfeld, Anna Horbaczewska, Ninela Irga-Jaworska, Robert Jach, Piotr Jędrzejczak, Izabela Kopeć, Maryna Krawczuk-Rybak, Maciej Krzakowski, Katarzyna Pogoda, Maria Sąsiadek, Robert Spaczyński, Monika Urbaniak, Elżbieta Wojciechowska-Lampka, Sławomir Wołczyński, Jacek Jassem

Vol 20, No 2 (2024)

Guidelines / Expert consensus

Comprehensive geriatric assessment and clinical outcomes of frail older adults with diffuse large B-cell lymphoma: a meta-analysis

Teodoro J. Oscanoa, Xavier Vidal, Brady E. Beltran, Roman Romero-Ortuno

Vol 19, No 6 (2023)

Review paper

Commentary to Effect of ribociclib plus fulvestrant on overall survival in the treatment of advanced breast cancer — updated MONALEESA-3 results

Barbara Radecka

Vol 18, No 3 (2022)

Commentary